References
- SchillingRFPlatelet millionairesLancet19803168190372373
- SoràFAutoreFChiusoloPExtreme thrombocytosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitorsLeuk Lymphoma201455122958296024684229
- VermaSPSubbiahAJacobSEBasuDChronic myeloid leukaemia with extreme thrombocytosisBMJ Case Rep20152015 ii: bcr2014204564
- ThakralBSalujaKMalhotraPSharmaRRMarwahaNVarmaSTherapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemiaTher Apher Dial20048649749915663550
- BalatzenkoGGuenovaMStoimenovAJotovGToshkovSPhiladelphia chromosome–positive chronic myeloid leukemia with p190BCR-ABL rearrangement, overexpression of the EVI1 gene, and extreme thrombocytosis: a case reportCancer Genet Cytogenet20081811757718262061
- KimSYJeonYLParkTSChronic myeloid leukemia with extreme thrombocytosisKorean J Hematol2012471722479272
- LiuSLiJJWagnFYA case of chronic myeloid leukemia onset with marked thrombocythemia and review of the literatureMod Med J China20151743033
- van Kooten NiekerkPBRougASPetersenCCChronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biologyBr J Haematol2013162114114423593974
- SokalJECoxEBBaccaraniMPrognostic discrimination in “good-risk” chronic granulocytic leukemiaBlood19846347897996584184
- HasfordJPfirrmannMHehlmannRA new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon AlfaWriting Committee for the Collaborative CML Prognostic Factors Project GroupJ Natl Cancer Inst199890118508599625174
- HasfordJBaccaraniMHoffmannVPredicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreBlood2011118368669221536864
- BaccaraniMDeiningerMWRostiGEuropean LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013Blood2013122687288423803709
- StollDBPetersonPExtenRClinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosomeAm J Hematol198827277833422539
- MichielsJJBernemanZSchroyensWPhiladelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemiaAnn Hematol200483850451215164229
- MorrisCMFitzgeraldPHHollingsPEEssential thrombocythaemia and the Philadelphia chromosomeBr J Haematol198870113193179224
- Chinese Society of Hematology, Chinese Medical AssociationThe guidelines for diagnosis and treatment of chronic myelogenous leukemia in China (2013 edition)Chin J Hematol2013345464470
- FrancisJDubashiBSundaramRPradhanSCChandrasekaranAInfluence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinibMed Oncol201532816
- YahngSAJangEJChoiSYComparison of Sokal, Hasford and EUTOS scores in terms of long-term treatment outcome according to the risks in each prognostic model: a single center data analyzed in 255 early chronic phase chronic myeloid leukemia patients treated with frontline imatinib mesylateBlood20121202127942794
- HochhausASaglioGHughesTPLong-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trialLeukemia20163051044105426837842
- Hjorth-HansenHStenkeLSöderlundSDasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)Eur J Haematol201594324325025082346
- Chinese Society of Hematology, Chinese Medical AssociationThe guidelines for diagnosis and treatment of chronic myelogenous leukemia in China (2016 edition)Chin J Hematol2016378633639
- SchaferAIBleeding and thrombosis in the myeloproliferative disordersBlood19846411126375757
- RiceLPopatUEvery case of essential thrombocythemia should be tested for the Philadelphia chromosomeAm J Hematol2005781717315609281
- TurakhiaSKMurugesanGCottaCVTheilKSThrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutationsJ Clin Pathol201669871371926754830
- KarakuşSÖzcebeOİHaznedaroğluİCCirculating thrombopoietin in clonal versus reactive thrombocytosisHematology20027191212171772